tiprankstipranks
Trending News
More News >
Zura Bio Launches TibuSHIELD Phase 2 Study for HS
PremiumCompany AnnouncementsZura Bio Launches TibuSHIELD Phase 2 Study for HS
1M ago
Zura Bio launches global Phase 2 TibuSHIELD study evaluating tibulizumab
Premium
The Fly
Zura Bio launches global Phase 2 TibuSHIELD study evaluating tibulizumab
1M ago
Zura Bio price target lowered to $17 from $19 at Oppenheimer
Premium
The Fly
Zura Bio price target lowered to $17 from $19 at Oppenheimer
2M ago
Zura Bio Limited: 2024 Financial Results and Strategic Progress
PremiumCompany AnnouncementsZura Bio Limited: 2024 Financial Results and Strategic Progress
3M ago
ZURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ZURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Zura Bio’s Growth Potential: Buy Rating Backed by Key Catalysts and Phase 2 Developments
Premium
Ratings
Zura Bio’s Growth Potential: Buy Rating Backed by Key Catalysts and Phase 2 Developments
4M ago
Zura Bio to Present at Healthcare Conference
PremiumCompany AnnouncementsZura Bio to Present at Healthcare Conference
7M ago
Zura Bio Announces Phase 2 Tibulizumab Study
Premium
Company Announcements
Zura Bio Announces Phase 2 Tibulizumab Study
7M ago
Zura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
Premium
The Fly
Zura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100